Increased C-reactive protein in young adult patients with migraine

Cephalalgia

Volumn 27, Issue 7, 2007, Pages 843-846

  Vanmolkot, F H ^a   De Hoon, J N ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

C reactive protein; Inflammation; Migraine

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA;

ADULT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; RISK FACTORS;

EID: 34250764772     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01324.x     Document Type: Article

References (15)

1. Bousser MG, Welch KM. Relation between migraine and stroke. Lancet Neurol 2005 4 : 533 42.
2. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ. Migraine as a risk factor for subclinical brain lesions. JAMA 2004 291 : 427 34.
3. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004 61 : 1366 8.
4. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003 34 : 1126 9.
5. Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 2005 64 : S9 15.
6. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003 34 : 2518 32.
7. Welch KM. Stroke and migraine - the spectrum of cause and effect. Funct Neurol 2003 18 : 121 6.
8. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005 36 : 1316 29.
9. Welch KM, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006 46 : 197 9.
10. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd., Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107 : 499 511.
11. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szkio M. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology 2005 64 : 1573 7.
12. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005 64 : 1020 6.
13. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006 296 : 283 91.
14. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005 112 : 900 5.
15. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005 64 : 614 20.